IP Library Patent Application 18195239
Patent Application
App. No. 18/195,239

REACTIVE GRANULATION OF CALCIUM CITRATE MALATE, DICALCIUM MALATE, AND DIMAGNESIUM MALATE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/195,239
Abstract

The present invention provides compositions comprising granules of calcium citrate malate, compositions comprising granules of dicalcium malate, compositions comprising granules of dimagnesium malate, methods for preparing these compositions, and dosage formulations of these compositions.

Claims (24)

1 . A composition comprising granules of calcium citrate malate having a mole ratio of calcium:malate:citrate of about 6:3:2 and a water content of at least 5.0 weight % (wt %).

2 . The composition of claim 1 , wherein the composition comprises at least one excipient.

3 . The composition of claim 1 , wherein the granules have a calcium weight percentage of at least 19 wt %.

4 . The composition of claim 1 , wherein the granules of calcium citrate malate have a particle size ranging from about 50 microns to about 1500 microns.

5 . The composition of claim 1 , wherein the granules have a bulk density of at least 0.70 g/mL.

6 . The composition of claim 1 , wherein the composition comprises no more than 5.0 wt % silica.

7 . A composition comprising granules of dicalcium malate having a mole ratio of calcium:malate of about 2:1 and a water content of at least 5.0 wt %.

8 . The composition of claim 7 , wherein the composition comprises at least one excipient.

9 . The composition of claim 7 , wherein the granules have a calcium weight percentage of at least 27 wt %.

10 . The composition of claim 7 , wherein the granules of dicalcium malate have a particle size ranging from about 50 microns to about 1500 microns.

11 . The composition of claim 7 , wherein the granules have a bulk density of at least 0.70 g/mL.

12 . The composition of claim 7 , wherein the composition comprises no more than 5.0 wt % silica.

13 . A composition comprising granules of dimagnesium malate having a mole ratio of magnesium:malate of about 2:1 and a water content of at least 2.0 wt %.

14 . The composition of claim 13 , wherein the composition comprises at least one excipient.

15 . The composition of claim 13 , wherein the granules have a magnesium weight percentage of at least 18 wt %.

16 . The composition of claim 13 , wherein the granules of dicalcium malate have a particle size ranging from about 50 microns to about 1500 microns.

17 . The composition of claim 13 , wherein the granules have a bulk density of at least 0.70 g/mL.

18 . The composition of claim 13 , wherein the composition comprises no more than 5.0 wt % silica.

19 . A dosage formulation comprising granules of the calcium citrate malate composition of claim 1 .

20 . The dosage formulation of claim 19 , wherein the dosage formulation is a tablet comprising compressed granules of calcium citrate malate.

21 . A dosage formulation comprising granules of the dicalcium malate composition of claim 7 .

22 . The dosage formulation of claim 21 , wherein the dosage formulation is a tablet comprising compressed granules of dicalcium malate.

23 . A dosage formulation comprising granules of the dimagnesium malate composition of claim 13 .

24 . The dosage formulation of claim 23 , wherein the dosage formulation is a tablet comprising compressed granules of dimagnesium malate.

Assignments (2)
SECURITY INTEREST Recorded Jul 24, 2026
From: ALBION LABORATORIES, INC.; BALCHEM CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075393/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2023
From: GONZALEZ, REN A.; JENNESS, TOD
To: BALCHEM CORPORATION
Reel/Frame 063645/0139 →